< Back

Christopher Marshallsay

Grünenthal GmbH
Leader background:
is a PhD biochemist, currently working as Director, Head Medical Writing and Public Disclosure at Grünenthal (Aachen, Germany), Christopher Marshallsay has 20 years of experience in various roles in clinical development - including pharmacokinetics, medical writing, clinical trial disclosure, and as department/function head - whilst located in Aachen, Frankfurt, and Paris. He previously worked at Ciba-Geigy, Aventis, and Sanofi. Christopher is an expert in continuous improvement and an experienced lecturer and workshop leader. In his current role he manages the team responsible for clinical trial disclosure in English-language trial registries worldwide, and drives alignment of company processes and standards to enable smart trial registration, status updating, and results reporting.
An Introduction to Clinical Trial Disclosure – the Regulatory Requirements, Industry Commitments, and Protection of Data Privacy and Company Confidential Information
    Level: Foundation Area: Drug Development
    Code: DDF36 Duration: 03:30:00
Publication of CSRs according to EMA Policy 0070 – Zurampic experience
    Level: Area:
    Code: Sym5.2 Duration: 00:30:00
Clinical Trial Registries and Public Databases - Gaining Efficiencies and Understanding Pitfalls
    Level: Area: Expert Seminar Series
    Code: ESS25 Duration:
An update on regulatory public disclosure - news, initiatives and changes to regulations
    Level: Area:
    Code: ESS32.4 Duration: 00:35:00